A number of reports point out a tumor suppressor function for GPC5 in several cancers, such as non-small cell lung cancer [13], lung adenocarcinoma [14], prostate cancer [15], pancreatic cancer [16], and glioma [17]. This evidence concerns the gene GPC5 and non-small cell lung carcinoma.